In several mouse autoimmune disease models including experimental autoimmune encephalomyelitis, collagen-induced arthritis, inflammatory bowel diseases, gastritis, thyroiditis, and autoimmune diabetes, GITR inhibition resulted in an anti-inflammatory effect. This evidence concerns the gene TNFRSF18 and inflammatory bowel disease.